Faculty Collaboration Database

1. Vali FS, Nagda S, Hall WA, Sinacore J, Gao M, Lee SH, Hong R, Shoup M, Emami B. Comparison of Standardized Uptake Value - Based Positron Emission Tomography and Computed Tomography Target Volumes in Esophageal Cancer Patients Undergoing Radiotherapy. Int J Radiat Oncol Biol Phys, 2010:78(4): 1057 - 1063. PMID: 20199850

2. Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK. Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol. 2011;2011:979214. PMCID: PMC3263656

3. Prabhu RS, Liebman L, Wojno T, Hayek B, Hall WA, Crocker I. Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. Radiat Oncol. 2012 Jun 19;7:95. PMCID: PMC3485155

4. Prabhu R, Shu HK, Hadjipanayis C, Dhabaan A, Hall WA, Raore B, Olson J, Curran WJ, Oyesiku N, Crocker I. Current Dosing Paradigm for Stereotactic Radiosurgery Alone After Surgical Resection Of Brain Metastases Needs to be Optimized for Improved Local Control. Int J Radiat Oncol Biol Phys, 2012; 83:e61-66. PMID: 22516387

5. Hall WA, Ali AN, Gullett N, Crocker I, Landry JC, Shu HK, Prabhu R, Curran W. Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. Cancer. 2012 Nov 01;118(21):5331-8. PMID: 22517327

6. Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB. Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. J Am Coll Radiol. 2013 Feb;10(2):128-34. PMID: 23245437

7. Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I. Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Mar 01;85(3):643-9. PMID: 22836055

8. Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC. Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2013 May 01;86(1):102-7. PMID: 23290442

9. Prabhu RS, Dhabaan A, Hall WA, Ogunleye T, Crocker I, Curran WJ, Shu HK. Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. J Neurooncol. 2013 May;113(1):93-9. PMID: 23440526

10. Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Cancer. 2013 Jun 15;119(12):2350-7. PMCID: PMC3904231

11. Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Cancer. 2013 Sep 01;119(17):3148-55. PMCID: PMC4389890

12. Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB. The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer. 2013 Sep 15;119(18):3272-9. PMID: 23818401

13. Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB. Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Pract Radiat Oncol. 2013 Oct-Dec;3(4):e157-64. PMID: 24674413

14. Prabhu RS, Magliocca KR, Hanasoge S, Aiken AH, Hudgins PA, Hall WA, Chen SA, Eaton BR, Higgins KA, Saba NF, Beitler JJ. Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. Int J Radiat Oncol Biol Phys. 2014 Jan 01;88(1):122-9. PMID: 24331658

15. Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer. 2014 Feb 15;120(4):499-506. PMCID: PMC4380170

16. Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. J Gastrointest Oncol. 2014 Apr;5(2):77-85. PMCID: PMC3999628

17. Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. Cancer Res. 2014 May 15;74(10):2677-87. PMCID: PMC4025946

18. Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. Cancer. 2014 May 15;120(10):1499-506. PMID: 24510454

19. Hall WA, Prabhu RS, Crocker I, Dhabaan A, Jiang X, Curran WJ, Kandula S, Oguleye T, Shu HG. Repeat Whole Brain Radiation Therapy with a Simultaneous Infield Boost: A Novel Technique for Reirradiation. Journal of Radiotherapy, vol. 2014, Article ID 403945, 8 pages, 2014. https://doi.org/10.1155/2014/403945.

20. Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. Int J Radiat Oncol Biol Phys. 2014 Jun 01;89(2):360-9. PMID: 24837891

21. Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. Oncogene. 2014 Nov 20;33(47):5450-6. PMID: 24276239

22. Dulaney C, Hall WA, Mikell JL, Pittal PM, Prabhu RS, Kooby DA, Hanley K, Sarmiento JS, Landry JC. The Influence of Time Interval Between Abdominal MRI Acquisition and Operative Date on Radiographic to Pathologic Size Discrepancy in Pancreatic Adenocarcinoma: Implications for Local Therapy. Journal of Biomedical Graphics and Computing. ePub Vol 4, No2, 2014. DOI: 10.5430/jbgc.v4n2p15

23. Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thorac Oncol. 2015 Mar;10(3):462-71. PMCID: PMC4336617

24. Cheng J, Squires MH, Mikell JL, Fisher SB, Staley CA, Kooby DA, Curran WJ, Hall WA, Colbert LC, Shelton JW, Maithel SK, Landry JC, Yu D. Radiotherapy Patterns Of Care in Gastric Adenocarcinoma: A Single Institutional Experience. J Gastrointest Oncol. 2015 Jun;6(3):247-53 PMCID: PMC4397246

25. Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015 Jun;37(6):777-82. PMID: 24596123

26. Tanenbaum DG, Hall WA, Mittal P, Nickleach D, Mikell JL, Colbert LE, Moreno CC, Squires MH, Fisher SB, Yu DS, Kooby DA, Maithel SK, Landry JC. Cholangiocarcinoma Size on MRI Versus Pathologic Specimen: Implications for Radiation Treatment Planning. Pract Radiat Oncol. 2016 May-Jun;6(3) PMID: 26979545

27. Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol. 2016 Apr 15;8(4):358-65. PMID 27096031.

28. Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS. TNFRSF10C copy number variation is associated with metastatic colorectal cancer. J Gastrointest Oncol. 2016 Jun;7(3):306-14. PMCID: PMC4880759

29. Lee WR, Dignam JJ, Amin M, Bruner D, Low D, Swanson GP, Shah AB, D’Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria S, Chen Y, Koontz BF, Paulus R, and Sandler HM. NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology, 2016 Jul 10;34(20):2325-32 PMID: 27044935

30. Heerkens HD, Hall WA, Li X.A, Knechtges P, Dalah E, Paulson ES, Vanden Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, Van Vulpen K, Erickson BA: Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiotherapy of pancreatic cancer. Pract Radiat Oncol. 2017 Mar - Apr;7(2):126-136. PMID: 28089481

31. Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY. Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. Semin Radiat Oncol. 2017 01;27(1):11-20. PMID: 27986207

32. Chen X, Oshima K, Schott D, Hall WA, Erickson B, Knechtges P, Wu H, Song YQ, Tao YL, Li DJ, Zheng C, Li XA; Assessment of Treatment Response During Chemoradiation Therapy for Pancreatic Cancer Based on Quantitative Radiomic Analysis of Daily CTs: An Exploratory Study; PLOS ONE; 2017 Jun 2; PMCID:PMC5456365

33. Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Cancer. 2017 Sep 15;123(18):3486-3493. PMCID: PMC5589506

34. Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? J Gastrointest Surg. 2017 Nov;21(11):1793-1803. PMID 28849366

35. Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA. Adaptive radiation dose escalation in rectal adenocarcinoma: a review. J Gastrointest Oncol. 2017 Oct;8(5):902-914. PMCID: PMC5674246

36. Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ Jr, Movsas B. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. 2018 Mar 30. PMID: 29618054

37. Hall WA, Heerkens HD, Paulson ES, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA. Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference. Pract Radiat Oncol. 2018 Mar - Apr;8(2):107-115. PMID: 29426692

38. Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA. Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. Transl Oncol. 2018 Apr;11(2):391-398. PMCID: PMC5852406

39. Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 Jul 9. PMID: 29984547

40. Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. Neurosurgery. 2018 May 01;82(5):595-603. PMID: 29669114

41. Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS. Optimized -value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. J Med Imaging (Bellingham). 2018 01;5(1):011004. PMCID: PMC5658575

42. Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys. 2018 Jun 01;101(2):274-284. PMID: 28964588

43. Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA. PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. Transl Oncol. 2018 Jul 13;11(5):1104-1109. PMCID: PMC6070701

44. Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst. 2018 May 1;110(5):460-466. PMID 29165692

45. Koay EJ, Hall W, Park PC, Erickson B, Herman JM. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY). 2018 Feb;43(2):393-403. PMCID: PMC5832555

46. McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS. Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 Aug 01;101(5):1179-1187. PMCID: PMC6190585

47. Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK. Locally advanced pancreas cancer: Staging and goals of therapy. Surgery. 2018 05;163(5):1053-1062. PMID: 29331400

48. Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA. Imaging predictors of treatment outcomes in rectal cancer: An overview. Crit Rev Oncol Hematol. 2018 Sep;129:153-162. PMID 30097234

49. Kerns SL, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B. Radiation biology and oncology in the genomic era. Br J Radiol. 2018 Nov;91(1091):20170949. PMCID: PMC6475928

50. Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan AH, Mackinnon AC, Tolat P, Ahmad AS, Hall WA Erickson BA, Evans DB. A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg. 2018 Oct;268(4):610-619. PMID: 30080723

51. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Ann Surg. 2018 Oct 11. PMID: 30312198

52. Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B. Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2019 May 01;5(5):664-670. PMCID: PMC6459051

53. Hall WA, Goodman KA. Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. Radiat Oncol. 2019 Jun 26;14(1):114. PMCID: PMC6595558

54. Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiother Oncol. 2019 Dec;141:137-143. PMCID: PMC6912855

55. Lorenz JW, Schott D, Rein L, Mostafaei F, Noid G, Lawton C, Bedi M, Li XA, Schultz CJ, Paulson E, Hall WA. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer. Cureus. 2019 Apr 20;11(4):e4510. PMCID: PMC6590865

56. Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. Eur J Cancer. 2019 Nov;122:42-52. PMCID: PMC8447225

57. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 2019 09;166(3):277-285. PMID 31272811

58. Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? J Gastrointest Surg. 2020 Feb;24(2):235-242. PMID: 31745905

59. Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA. Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. J Natl Compr Canc Netw. 2019 07 01;17(7):829-837. PMID: 31319388

60. Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, Hall W, Erickson B, Li XA. Variations of MRI-assessed peristaltic motions during radiation therapy. PLoS One. 2018;13(10):e0205917. PMCID: PMC6201905

61. Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2019 Sep - Oct;9(5):322-332. PMID: 31474330

62. Schott D, Schmidt TG, Hall W, Knechtges P, Noid G, Klawikowski S, Erickson B, Li XA. Estimation of changing gross tumor volume from longitudinal CTs during radiation therapy delivery based on a texture analysis with classifier algorithms: a proof-of-concept study. Quant Imaging Med Surg. 2019 Jul;9(7):1189-1200. PMCID: PMC6685807

63. Zhang, Y; Paulson, E; Lim, S; Hall, W; Ahunbay, E; Mickevicius, N; Straza, M; Erickson, B; Li, X Allen; "A patient-specific auto-segmentation strategy using multi-input deformable image registration for MRI-guided online adaptive radiotherapy: a feasible study" Adv Radiat Oncol . 2020 May 16;5(6):1350-1358. doi: 10.1016/j.adro.2020.04.027. PMID: 33305098

64. Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B. Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Pract Radiat Oncol. 2020;10(6):e495-e507. PMCID: PMC7423616

65. Lukovic J, Henke L, Gani C, Kim TK, Stanescu T, Hosni A, Lindsay P, Erickson B, Khor R, Eccles C, Boon C, Donker M, Jagavkar R, Nowee ME, Hall WA, Parikh P, Dawson LA. MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology. Int J Radiat Oncol Biol Phys. 2020 03 15;106(4):743-753. PMID: 31953061

66. Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. JAMA Oncol. 2020 May 01;6(5):735-743. PMCID: PMC7189892

67. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. HPB (Oxford) Dec;22(12):1745-1752. doi: 10.1016/j.hpb.2020.03.022. Epub 2020 Apr 27. PubMed PMID: 32354656

68. Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Front Oncol. 2020;10:460. PMCID: PMC7175033

69. Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience. Clin Transl Radiat Oncol. 2020 Jul;23:72-79. PMCID: PMC7256110

70. Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Ann Surg Oncol. 2021 Apr;28(4):2246-2256. PMID 33000372

71. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. Surgery. 2020 09;168(3):440-447. PMID: 32641278

72. Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY. Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. Surgery. 2021 03;169(3):629-635. PMID: 32826069

73. Hall WA, Sabharwal L, Udhane V, Maranto C, Nevalainen MT. Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy. Int J Biochem Cell Biol. 2020 Oct;127:105827. PMCID: PMC8638530

74. Kooreman ES, van Houdt PJ, Keesman R, Pos FJ, van Pelt VWJ, Nowee ME, Wetscherek A, Tijssen RHN, Philippens MEP, Thorwarth D, Wang J, Shukla-Dave A, Hall WA, Paulson ES, van der Heide UA. ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium. Radiother Oncol. 2020 Dec;153:106-113. PMCID: PMC8327388

75. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Front Oncol. 2020;10:1328. PMCID: PMC7505056

76. Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F. Development and validation of a genomic tool to predict seminal vesicle invasion in adenocarcinoma of the prostate. JCO Precision Oncology. 2020;4:1228-1238. PMID: 35050780

77. Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. PLoS One. 2020;15(8):e0236570. PMCID: PMC7413561

78. Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 Jan 01;109(1):174-185. PMCID: PMC7736505

79. Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA. A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study. Adv Radiat Oncol. 2020;5(6):1350-1358. PMCID: PMC7718500

80. Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. Am J Surg. 2021 07;222(1):10-17. PMID: 33308823

81. Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR. Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. Clin Genitourin Cancer. 2021 06;19(3):267-270.e1. PMID: 33191148

82. Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF. Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. Pract Radiat Oncol. 2021;11(6):527-533. PMCID: PMC8638529

83. Feng FY, Huang HC, Spratt DE, Zhao SG, Sandler HM, Simko JP, Davicioni E, Nguyen PL, Pollack A, Efstathiou JA, Dicker AP, Todorovic T, Margrave J, Liu YS, Dabbas B, Thompson DJS, Das R, Dignam JJ, Sweeney C, Attard G, Bahary JP, Lukka HR, Hall WA, Pisansky TM, Shah AB, Pugh SL, Shipley WU, Tran PT. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial. JAMA Oncol. 2021 Apr 01;7(4):544-552. PMCID: PMC7879385

84. Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C. The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? Clin Transl Radiat Oncol. 2021 May;28:124-128. PMCID: PMC8085778

85. Nasief H, Zheng C, Schott D, Hall W, Tsai S, Erickson B, Allen Li X. A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. NPJ Precis Oncol. 2019;3:25. PMCID: PMC6778189

86. Hall WA, Erickson B, Crane CH. Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer. Surg Oncol Clin N Am. 2021 Oct;30(4):719-730. PMCID: PMC8462521

87. Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Front Oncol. 2021;11:628155. PMCID: PMC8144850

88. Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS. Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. Cancer Metastasis Rev. 2021 Sep;40(3):879-889. PMCID: PMC8767496

89. van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. Eur J Cancer. 2021 Aug;153:64-71. PMCID: PMC8340311

90. Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA. Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. Pract Radiat Oncol. 2021 Nov-Dec;11(6):453-459. PMID: 34742459

91. Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021 Aug 01;7(8):1225-1230. PMCID: PMC8251652

92. Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT. Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? Cancers (Basel). 2021 Oct 17;13(20). PMCID: PMC8533841

93. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium. Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. Int J Radiat Oncol Biol Phys. 2021 11 15;111(4):867-875, PMID: 34265394.

94. Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD. Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. CA Cancer J Clin. 2022 Jan;72(1):34-56. PMCID: PMC8985054

95. Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B. Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. Int J Radiat Oncol Biol Phys. 2022 Jan 01;112(1):83-92. PMCID: PMC8789217

96. Damico N, Meyer J, Das P, Murphy J, Miller E, Koontz B, Hall W, McBride M, Pereira G, Catalano P, Chakravarthy AB, O'Dwyer PJ, Dorth J. ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT. Pract Radiat Oncol. 2022 Jul-Aug;12(4):335-347. PMID: 35717050

97. Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM. Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer. J Gastrointest Oncol. 2022 Feb;13(1):185-196. PMCID: PMC8899735

98. Janssen TM, Aitken K, Alongi F, Barry A, Bernchou U, Boeke S, Hall WA, Hosni A, Kroon PS, Nachbar M, Saeed H, Jürgenliemk-Schulz IM, Schytte T, Verkooijen HM, Nowee ME, tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium. First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac. Tech Innov Patient Support Radiat Oncol. 2022 Jun;22:50-54. PMCID: PMC9108982

99. Gough J, Hall W, Good J, Nash A, Aitken K. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation. Clin Oncol (R Coll Radiol). 2022 May;34(5):301-312.2022. PMID: 35305888

100. Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L. Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. Pract Radiat Oncol. 2022 May 26;S1879-8500(22)00158-8. PMID: 35644469

101. Jackson WC, Tang M, Schipper MJ, Sandler HM, Zumsteg ZS, Efstathiou JA, Shipley WU, Seiferheld W, Lukka HR, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Hall WA, Dess RT, Lovett RD, Balogh AG, Feng FY, Spratt DE. Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601. J Clin Oncol. 2022 Sep 20;40(27):3172-3179. PMCID: PMC9514834

102. Amjad A, Xu J, Thill D, Lawton C, Hall W, Awan MJ, Shukla M, Erickson BA, Li XA. General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis. Med Phys. 2022 Mar;49(3):1686-1700. PMCID: PMC8917093

103. Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. Radiother Oncol. 2022 03;168:75-82. PMCID: PMC8986577

104. Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom CR, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High Risk Prostate Cancer: A Validation Study from NRG/RTOG 0521. Int J Radiat Oncol Biol Phys. 2022 Jun 05. PMID: 35675855

105. Zhang Y, Liang Y, Ding J, Amjad A, Paulson E, Ahunbay E, Hall WA, Erickson B, Li XA. A Prior Knowledge-Guided, Deep Learning-Based Semiautomatic Segmentation for Complex Anatomy on Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys. 2022 Oct 01;114(2):349-359. PMCID: PMC9639200

106. Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. Eur Urol. 2022 Dec;82(6):613-622.

107. Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WA. A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. Ann Surg Oncol. 2023 Feb;30(2):688-690. PMCID: PMC10688344

108. Parchur AK, Lim S, Nasief HG, Omari EA, Zhang Y, Paulson ES, Hall WA, Erickson B, Li XA. Auto-detection of necessity for MRI-guided online adaptive replanning using a machine learning classifier. Med Phys. 2023 Jan;50(1):440-448. PMCID: PMC9868055

109. Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR. Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. 2023 Apr;6(2):204-211.

110. Nasief HG, Parchur AK, Omari E, Zhang Y, Chen X, Paulson E, Hall WA, Erickson B, Li XA. Predicting necessity of daily online adaptive replanning based on wavelet image features for MRI guided adaptive radiation therapy. Radiother Oncol. 2022 Oct 07;176:165-171. PMID: 36216299

111. Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. Int J Radiat Oncol Biol Phys. 2023 Jul 01;116(3):521-529. PMCID: PMC10281690

112. Hall WA, Kishan AU, Hall E, Nagar H, Vesprini D, Paulson E, Van der Heide UA, Lawton CAF, Kerkmeijer LGW, Tree AC. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. Front Oncol. 2022;12:962897. PMCID: PMC9484536

113. Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2022 Sep 13. PMID: 36108891

114. Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS. Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy. Adv Radiat Oncol. 2023;8(1):101122. PMCID: PMC9720358

115. Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA. Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Adv Radiat Oncol. 2023;8(4):101206. PMCID: PMC10157111

116. Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2):370-377. PMCID: PMC10949135

117. Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S. Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. Ann Surg. 2023 Dec 01;278(6):e1224-e1231.

118. DeSilvio T, Antunes JT, Bera K, Chirra P, Le H, Liska D, Stein SL, Marderstein E, Hall W, Paspulati R, Gollamudi J, Purysko AS, Viswanath SE. Region-specific deep learning models for accurate segmentation of rectal structures on post-chemoradiation T2w MRI: a multi-institutional, multi-reader study Frontiers in Medicine. 2023;10.

119. Lee SL, Hall WA, Morris ZS, Christensen L, Bassetti M. MRI-Guided Radiation Therapy. Adv Oncol. 2021 May;1:29-39. PMCID: PMC10104451

120. Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Value of Pretreatment ¹⁸F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. Front Oncol. 2020;10:500. PMCID: PMC7180175

121. Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience Clinical and Translational Radiation Oncology. July 2020;23:72-79.

122. Sharma G, Razeghi Kondelaji MH, Sharma GP, Hansen C, Parchur AK, Shafiee S, Jagtap JM, Fish B, Bergom C, Paulson E, Hall WA, Himburg HA, Joshi A. X-ray and MR Contrast Bearing Nanoparticles Enhance the Therapeutic Response of Image-Guided Radiation Therapy for Oral Cancer. Technol Cancer Res Treat. 2023;22:15330338231189593. PMCID: PMC10363893

123. Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. J Clin Oncol. 2023 Oct 10;41(29):4643-4651. PMCID: PMC10564288

124. Mheid S, Allen S, Ng SSW, Hall WA, Sanford NN, Aguilera TA, Elamir AM, Bahij R, Intven MPW, Radhakrishna G, Mohamad I, De Leon J, Tan H, Lewis S, Gani C, Stanecu T, Dell'Acqua V, Hosni A. Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century. Curr Oncol. 2023 Oct 19;30(10):9230-9243. PMCID: PMC10605011

125. Eijkelenkamp H, Grimbergen G, Daamen LA, Heerkens HD, van de Ven S, Mook S, Meijer GJ, Molenaar IQ, van Santvoort HC, Paulson E, Erickson BA, Verkooijen HM, Hall WA, Intven MPW. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac. Front Oncol. 2023;13:1040673. PMCID: PMC10579578

126. de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA. Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. Cancer Med. 2023 Dec 22;13(1). PMCID: PMC10807686

127. Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA. Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator. Phys Imaging Radiat Oncol. 2023 Oct;28:100504. PMCID: PMC10682663

128. Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Rödel C, Dasari A, Yoshino T. Future direction of total neoadjuvant therapy for locally advanced rectal cancer. Nat Rev Gastroenterol Hepatol. 2024 Mar 14.

129. George B, Kudryashova O, Kravets A, Thalji S, Malarkannan S, Kurzrock R, Chernyavskaya E, Gusakova M, Kravchenko D, Tychinin D, Savin E, Alekseeva L, Butusova A, Bagaev A, Shin N, Brown JH, Sethi I, Wang D, Taylor B, McFall T, Kamgar M, Hall WA, Erickson B, Christians KK, Evans DB, Tsai S. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2024 May;166(5):859-871.e3.

130. Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW. Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study. Clin Transl Radiat Oncol. 2024 Mar;45:100721. PMCID: PMC10808928

131. Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, Tree AC. Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability. Int J Radiat Oncol Biol Phys. 2024 Feb 01;118(2):378-389.

132. Daamen LA, Parikh PJ, Hall WA. The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. Semin Radiat Oncol. 2024 Jan;34(1):23-35.

133. Westerhoff JM, Daamen LA, Christodouleas JP, Blezer ELA, Choudhury A, Westley RL, Erickson BA, Fuller CD, Hafeez S, van der Heide UA, Intven MPW, Kirby AM, Lalondrelle S, Minsky BD, Mook S, Nowee ME, Marijnen CAM, Orrling KM, Sahgal A, Schultz CJ, Faivre-Finn C, Tersteeg RJHA, Tree AC, Tseng CL, Schytte T, Silk DM, Eggert D, Luzzara M, van der Voort van Zyp JRN, Verkooijen HM, Hall WA. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy. JAMA Netw Open. 2024 May 01;7(5):e2410819. PMCID: PMC11063805

134. Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ. ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. medRxiv. 2024 Apr 27. PMCID: PMC11071544

1. Hall WA, Curran W. Central Nervous System Tumors. Technical Basis of Radiation Therapy: Practical Clinical Applications. Seymour Levitt, James A Purdy, Carlos Perez, Philip Poortmans. Springer, Heidelberg Germany, 2012

2. Hall WA, Prabhu R, Staley C, Landry JC. The Role of Radiation Therapy in the Management of Non-Metastatic Rectal Cancer: Early and Locally Advanced Disease. Cancers of the Colon and Rectum: A Multidisciplinary Approach to Diagnosis and Management. Editors: Al Benson, Bapsi Chakravarthy, Stan Hamilton and Elin Sigurdson, 2012

3. Hall WA, Heerkens HD, Paulson EA, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA. Pancreatic Gross Tumor Volume Contouring on Computed Tomography as Compared with MRI, Results of an International MRI Consensus Contouring Conference. PhD thesis Text Book, Hanne Heerkens, Utrecht University, the Netherlands, Utrecht 2017. Chapter 8: pp 147-160. ISBN 978-90-393-6842-8

4. Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GI, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BE. Recommendations for MRI-based contouring of gross tumor volume and organs a risk for radiation therapy of pancreatic cancer in Towards online MRI guided radiotherapy for pancreatic cancer. PhD thesis Text Book, Hanne Heerkens, Utrecht University, the Netherlands, Utrecht 2017. Chapter 7: pp 125-144, ISBN 978-90-393-6842-8

5. Barnes CA, Erickson B, Hall WA, Evans D, Tsai S; Neoadjuvant Chemoradiation for Operable Pancreatic Cancer: The Importance of Local Disease Control; Springer 2018; The Importance of Local Disease Control. Springer Science Business Media LLC, 233 Spring Street, New York, NY 10013, U.S.A. (2017); 1-20. 10.1007/978-1-4939-6631-8_95-1.

1. Hall WA, Torres MT. Commentary On: "Irradiation Effect After Mastectomy on Breast Cancer Recurrence in Patients Presenting with Locally Advanced Disease" Breast Diseases: A Year Book Quarterly Vol 23, No. 2, July - September 2012.

2. Hall WA, Erickson B; Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly; JOP; April 10, 2017 from 141.106.128.044. PMID: 28282275

3. Kishan AU, Hall WA, Spratt DE. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? Eur Urol. 2019 May;75(5):e133-e134.

4. Hall WA. Opportunities and Challenges of Genomically Guided Decision Making for Patients With Prostate Cancer. Pract Radiat Oncol. 2020;10(2):93-94.

5. Hall WA, Tree AC, Dearnaley D, Parker CC, Prasad V, Roach M 3rd, Lawton CAF. Considering benefit and risk before routinely recommending SpaceOAR. Lancet Oncol. 2021 Jan;22(1):11-13. PMCID: PMC8882263

6. Hall WA, Lawton CAF, coauthors. In Reply to Onal et al. Int J Radiat Oncol Biol Phys. 2021 Jun 01;110(2):620-621.

7. Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. J Clin Oncol. 2021 Dec 01;39(34):3773-3777. PMCID: PMC8608256

8. Hall WA, Smith JJ. Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma. J Clin Oncol. 2023 Jan 10;41(2):173-180. PMCID: PMC9839271

9. Hall WA, Shoag J, Spratt DE. Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study. Eur Urol. 2022 Dec;82(6):661-662.

10. Hall WA, Lawton CAF. Confirming and Refining Our Existing Postoperative Treatment Strategies Through the Use of Novel Prostate-Specific Positron Emission Tomography (PET) Imaging. Int J Radiat Oncol Biol Phys. 2023 Jan 01;115(1):118-119.

11. Hall WA, Evans DB, Tsai S. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. JAMA Oncol. 2023 Feb 01;9(2):275-276.

12. Hall WA, Shoag J, Spratt DE. Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study European Urology. December 2022;82(6):661-662.

13. Sanford NN, Hong TS, Hall WA. Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection. J Clin Oncol. 2024 Mar 10;42(8):868-871.

14. Sanford NN, Hall WA, Booth CM. Re-Examining Trials of Radiotherapy Omission: When Less Is Not Always More. JCO Oncol Pract. 2024 Apr;20(4):460-462.

1. Iyengar R, Hall WA, Henderson K, Russell B, Samarel A. Stretch-Induced Akt Phosphorylation/Dephosphorylation In Cardiac Myocytes. Federation of American Societies for Experimental Biology (FASEB) J 21:908.28, 2007.

2. Hall WA, Senthi A, Nagda S, Love R. Importance of Image Guided Patient Setup in Stereotactic Body Radiation Therapy (SBRT) of Early Stage NSCLC. American Society for Radiation Oncology, 2008 Multidisciplinary Symposium in Thoracic Oncology. Abstract #155, poster presentation.

3. Grecula JC, Hall WA, Hoang T, Mayr N, Ross P. Modulation of Radiation Response of Head and Neck Cancer Cells with Poly (ADP-Ribose) Polymerase Inhibitor-ABT 888, International Journal of Radiation Oncology Biology, Physics, Sep 2008, Vol 72.

4. Hall WA, Wang L, Clarke J, Otterson G. Modulation of Radiation Response of Non-Small Cell Lung Cancer Cells with Poly (ADP-Ribose) Polymerase Inhibitor: ABT-888, International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology, Sep 2008, Vol 72.

5. Vali F, Hall WA, Gao M. Inter-Fraction 3-Dimensional Variations/Motion/Shifts of Hotspots in the Bladder and Rectum During CT-Guided HDR Brachytherapy of the Cervix: Are We Over Estimating the Dose to the Organs at Risk? International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology, Sep 2008, Vol 72.

6. Hall WA, Chen Z, Jiang X, Dhabban A, Crocker I. Safety and Efficacy of Fractionated Stereotactic Radiotherapy and Stereotactic Radiosurgery in the Treatment of Functioning and Non-Functioning Pituitary Tumors. American Society for Radiation Oncology 2010, International Journal of Radiation Oncology, Biology, Physics, Vol 78 (3) S289.

7. Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB. Treatment of Efficiency of Volumetric Modulated Arc Therapy (VMAT in Comparison to Intensity Modulated Radiotherapy (IMRT) in the Treatment of Prostate Cancer. American Society for Radiation Oncology 2011, International Journal of Radiation Oncology, Biology, Physics, Vol 81 S2.

8. Hall WA, Ali AN, Gullet N, Crocker I, Landry JC, Shu H, Prabhu RS, Curran WJ. Comparing CNS and Extra CNS Hemangiopericytomas in the Surveillance, Epidemiology and End Results Program, an Analysis of 655 Patients. American Society for Radiation Oncology 2011, International Journal of Radiation Oncology, Biology, Physics, Vol 81 S2.

9. Hall WA, Rossi PJ, Godette K, Jani AB. Improvement in Acute GI and GU Toxicities with the Use of Volume Modulated Arc Therapy (VMAT) in the Treatment of Adenocarcinoma of the Prostate. American Radium Society, 2012. Poster presentation.

10. Hall WA, Rossi PJ, Cooper S, Master VA, Jani AB. C-Reactive Protein (CRP): Initial Exploratory Study of an Inflammatory Biomarker for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology 2012 Poster Presentation.

11. Prabhu R, Shu HK, Hadjipanayis C, Dhabaan A, Hall W, Raore B, Olson J, Curran W, Oyesiku N, Crocker I. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. Int J Radiat Oncol Biol Phys. 2012 May 01;83(1):e61-6.

12. Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Landry JC. Influence of Adjuvant Radiation Therapy Doses and Fractionation on Overall Survival for Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics, American Society for Radiation Oncology 2012.

13. Mikell J, Hall WA, Mittal P, Prabhu RS, David K, Hanley K, Colbert LE, Landry JC. Tumor Size on Abdominal MRI Versus Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiotherapy Planning. International Journal of Radiation Oncology, Biology, Physics. Digital poster discussion American Society for Radiation Oncology 2012.

14. Colbert LE, Hall WA, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Landry JC. Radiation Therapy Sequencing for Resected Pancreatic Adenocarcinoma. ASCO GI Cancers Symposium, San Francisco CA, January 24-26, 2013.

15. Hall WA, Nickleach DN, Switchenko J, Lipcomb J, Goodman M, Ward KC, Gillespie T. The Use of Radiation Therapy for Adenocarcinoma of the Prostate in Rural Georgia: A population Based Analysis. ASCO GU Cancers Symposium, January 16-18, 2014.

16. Hall WA, Pugh S, Wefel J, Armstrong T, Gilbert M, Brachman D, Werner-Wasik M, Wendland M, Brown P, Chao S, Roof K, Robins H, Curran W, Mehta M; Association of Neurocognitive and Patient Reported Outcomes with the Presence of Residual Disease Following Surgical Resection of Glioblastoma: Combined Secondary Analysis of NRG Oncology RTOG 0525 and 0825; Society for Neuro-Oncology; Oral Presentation; 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology; Miami, FL; November, 2014

17. Dalah E, Oshima K, Hall WA, Erickson B. PET-Based Treatment Response Assessment for Neoadjuvant Chemoradiation for Pancreatic Adenocarcinoma. Annual Meeting of the American Association of Physicists in Medicine, Anaheim, CA, July 12-16, 2015.

18. Dalah E, Oshima K, Hall WA, Knechtges P, Erickson B, Li XA; Correlation of CT Numbers with Radiation Treatment Response for Pancreatic Cancer; American Association of Physicists in Medicine Annual Meeting Poster Presentation; Anaheim, California; July, 2015

19. Chen XV, Zhang J, Dalah E, Liu F, Hall WA, Erickson. Change of CT Number During the Course of Chemoradiation Therapy for Pancreatic Cancer. Poster presentation at the Annual Meeting of the American Association of Physicists in Medicine in Anaheim, CA, July 12-16, 2015.

20. Paulson E, Hall WA, Robbins J; Feasibility of Diffusion Weighted MR Lymphography for Cervical Lymph Node Delineation in Head and Neck Cancer; American Society for Radiation Oncology Oral Presentation; San Antonio, TX, September, 2015

21. Dalah E, Tai A, Oshima K, Paulson ES, Hall WH, Erickson BA, Li A. Correlation of ADC with Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. Poster presentation at the American Society for Radiation Oncology 57th annual meeting, San Antonio, TX, October 18-21, 2015.

22. Hall WA, Pugh SL, Gilbert MR, Wefel JS, Armstrong T, Wendland MM, Brachman DG, Roof KS, Brown PD, Crocker IR, Robins HI, Lee RJ, Chao ST, Kim L, Srkalovic G, Fisch BM, Mehta MP, Curran WJ, Movsas B. Benvacizumab use in Patients with Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825. Oral presentation at the American Society for Radiation Oncology 57th annual meeting, San Antonio, TX, October 18-21, 2015

23. Paulson E, Hall WA, Robbins J. Feasibility of Diffusion Weighted MR Lymphography for Cervical Lymph Node Delineation in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov:93 (3), E604.

24. Chen X, Schott D., Song Y, Hall WA, Erickson B, Li XA. Radiation-Induced Changes in CT Number Histogram During Chemoradiation Therapy for Pancreatic Cancer, June 2016, Medical Physics. American Association of Physicists in Medicine.

25. Schott D,T, Schmidt, X, Chen, S. Klawikowski, G. Hall, WA, Noid, E, Dalah, X, Li, A. Statistical Segmentation On Quantitative CT for Assessing Spatial Tumor Response During Radiation Therapy Delivery, American Association of Physicists in Medicine Annual Meeting and Exhibition, Washington, DC, July 31 – August 4, 2016

26. Moningi S, Amer A, Hall WA, Erickson B, Varadhachary GR, Das P, Taniguchi CM, Fleming JB, Katz M, Crane CH,Koay EJ; A Computed Tomography Imaging Picture of Pancreatic Cancer as a Predictive Biomarker for Escalated Dose Radiation Therapy; American Society for Radiation Oncology; Poster Presentation; Boston, MA, September, 2016

27. Hall, WA, Paulson, E, Erickson, B, Li, X, Vicstocky, A, Tsai, S, Koay, E, Knechges, P, Evans, D, Christian, K, Ritch, P, Geroge, B, Oshima, K; Pancreatic Magnetic Resonance Imaging (MRI) and Computer Tomography (CT) Radiomic Metrics Correlate with Pathologic Molecular: An Exploratory Analysis; Poster Presentation, 2016 American Society for Radiation Oncology 58th Annual Meeting; Boston, MA; September, 2016

28. Watkins Bruner D, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B. NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S2-S3.

29. Schott D, Hall WA, Gilat Schmidt T, Dalah E, Oshima K, Paulson ES, Knechtges PM, Erickson BA, Li A. Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S70.

30. Blitzer G, Hall WA, Tsai S, Aldakkak M, Hellman R, Evans D, Christians K, George B, Ritch P, Erickson B; Should Functional Renal Scans be Obtained Prior to Upper Abdominal Radiation for Pancreatic Cancer?; DOI: 10.1200/JCO.2017.35.4_suppl.442 Journal of Clinical Oncology 35, no. 4_suppl (February 1 2017) 442-442; Presented as a poster at the 2017 Gastrointestinal Cancers Symposium in San Francisco, California from January 19-21, 2017.

31. Colbert LE, Dharmarajan KV, Switchenko J, Taniguchi CM, Hall WA, Gillespie TW, Kooby DA, Lipscomb J, Landry JC. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S195.

32. Hall WA; Pancreatic Magnetic Resonance Imaging (MRI) and Computer Tomography (CT) Radiomics Metrics Correlate with Pathologic Molecular Markers: An Exploratory Analysis; 51st Annual Pancreas Club Meeting; Poster Presentation; Chicago, IL; February, 2017

33. Chen XF, Prior P, Hall WA, Erickson E, Herman J, Li XA; An Analysis on Local Control of Chemoradiotherapy for the use of the Locally Advanced Pancreatic Cancer Using a Bio-Physical Model; American Society for Radiation Oncology; Oral Presentation, San Diego, CA; September, 2017; Int J Radiat Oncol Biol Phys 2017, 99(2S)S166

34. Hall, WA, Heerkens, H, Paulson, E, Meijer, G, Kotte, A, Knechtges, P, Parikh, P, Bassetti, M Lee, P, Aitken, K, Palta, M, Myrehaug, S, Koay, E, Portelance, L, Ben-Josef, E, Erickson, B; Pancreatic Adenocarcinoma Gross Tumor Volume Contouring On Computed Tomography (CT) As Compared With Magnetic Resonance Imaging (MRI), Results Of An International Consensus Contouring Conference; Int J Radiat Oncol Biol Phys, September, 2017

35. Hall, WA, Eastwood, D, Kilari, D, Van Wickle, J, Raychaudhuri, R, Borkenhagen, J, See, W, Lawton, C; Androgen Deprivation Therapy (ADT) and Radiation Therapy (RT) Alone As Compared with Trimodality Therapy With ADT, RT, and Surgery In Men With High Risk, Non-Metastatic Adenocarcinoma Of The Prostate; Int J Radiat Oncol Biol Phys, September, 2017

36. Borkenhagen J, Lawton C, Eastwood D, Kilari D, See W, Van Winkle JD, Hall WA; Prognostic value of clinical stage T2 substages in prostate cancer: A national cancer database review; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster

37. Mostafaei F, Tai A, Paulson E, Hall WA, Erickson BE, Li XA; Quantifying complex abdominal organ motions in different time frames in radiation therapy; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster

38. Chen XV, Schott D, Hao Y, Hall WA, Erickson B, Oshima K, Li XA; A quantitative analysis on CT histogram features before chemoradiation therapy for pancreatic cancer; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster

39. Schott, Hall WA, Paulson E, Erickson B, Oshima K, Knechtges P, Li XA; Treatment Response Assessment Using Quantitative DCE MRI for Chemoradiation Therapy of Pancreatic Cancer; American Society for Radiation Oncology; e-poster presentation; San Diego, CA; September, 2017; Int J Radiat Oncol Biol Phys 2017, 99(2S)S195.

40. Saeed H, Cheng H, Aldakkak M, Tsai S, Evans DB, Christians K, Thomas J, George B, Ritch P, Wittmann D, Hall WA, Erickson B. Neoadjuvant Chemoradiation with IMRT for Pancreatic Cancer is associated with Minimal Toxicity without compromising Local Control. Poster presentation at American Society for Radiation Oncology 59th annual meeting, San Diego, CA. September 24-27, 2017.

41. Schoot D, Hall WA, Chen XV, Klawikowski S, Noid G, Erickson B, Knechtges P, Gilat Schmidt T, Li XA; Machine Learning and Texture Analysis for Assessing Spatial Tumor Response Based on Daily CTs During Radiation Therapy for Pancreatic Adenocarcinomas; American Association of Physicists in Medicine; Poster Presentation, 2017

42. Van Wickle J.D, Rein L, Smith E, Berger N.G, Gamblin T.C, George G, Ritch P, Yen T, Tsai S, Christians K, Evans D.B, Robbins J.R, Erickson B.A, Hall WA; Sequencing of Chemotherapy and Radiation Therapy in the Treatment of Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma; Nov, 2017; 103rd Annual RSNA; Chicago, IL; SSJ24-05

43. George T, Rea W, Yothers G, Hong T, Russell M, You YN, Pogue-Geile K, Gollub M, Hall WA, Rahma O, Kachnic LA, Parker W, Jacobs S, Wolmark N; NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer; 2018 Gastrointestinal Cancers Symposium; January 2018, San Diego, CA

44. Nasief H, Hall WA, Schott D, Klawikowski S, Erickson B, Zheng C; Delta Radiomics of Daily CTs Acquired During Chemoradiation Therapy of Pancreatic Cancer; American Association of Physicists in Medicine, Oral Presentation; Nashville, TN; July, 2018

45. Mostafaei F, Tai A, Paulson E, Hall WA, Erickson B, Liu Q, Li XA; Inter and Intra Patient Peristaltic Motion Assessed with Cine MRI; American Society for Radiation Oncology, e-Poster, San Antonio, TX; October, 2018

46. Kinchen CL, Zhang U, Hall WA, Erickson B, Li XA; Characterizing Interfraction Variation of Separation between Pancreas and Duodenum During Radiotherapy of Pancreatic Cancer for Online Adaptive Replanning; American Society for Radiation Oncology; e-Poster Presentation, San Antonio, TX; October, 2018

47. Fain R, Lorenz J, Chen XV, Li A, Erickson B, Hall WA; The Unity of Position Emission Tomography (PET) to Guide Radiation Therapy Target Volume Determination as Compared with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) for Rectal Cancer; American Society for Radiation Oncology; e-Poster Presentation; San Antonio, TX; October, 2018

48. Prior P, Chen X, Hall WA, Erickson B, Li XA; Estimation of the Alpha-Beta Ratio for Chemoradiation of Locally Advanced Pancreatic Cancer; American Society for Radiation Oncology; Oral Presentation; San Antonio, TX; October, 2018

49. Hall WA; Liu S, Fishbane N, Xu M, Daviciono E, Mahal B, Den R, Dess R, Jackson W, Wong A, Schaeffer E, Karnes R, Carroll P, Nguyen P, Lawton C, Spratt D, Feng F; Development and Validation of Genomic Tools to Predict Extraprostatic Extension of Prostate Cancer, Opportunities for Personalizing Treatment; American Society for Radiation Oncology; Oral Presentation 200; San Antonio, TX; October, 2018

50. Hall WA, Karrison T, Rosenthal S, Amin M, Gomella L, Purdy J, Sator O, Michalski J, Garzotto M, Bergom C, Jani A, Lawton C, Simko J, Moore J, Gore E, Robert Lee W, Nguyen P, Danielson B, Sandler H, Feng F; The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521; American Society for Radiation Oncology; Oral Presentation 25; San Antonio, TX; October, 2018

51. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.

52. Mickevicius, N; Straza, M; Hall, W; Paulson, E; "First Clinical Use of 4D-MRI for Online Adaptive MR-gRT on a High Field MR-Linac" 2/22/2019.

53. Hall, W; Bedi, M; Kilari, D; Bylow, KA; Burfeind, J; See, W; Straza, MW; Lawton, CAF; "Safety and Feasibility of Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with A Simultaneous Hypo-fractionated Boost to the Prostate for High Risk Adenocarcinoma of the Prostate, a Prospective Phase II Clinical Trial" 2/23/2019. Astro IJORBP Se32

54. Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA. A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer Physics and Imaging in Radiation Oncology. October 2019;12:22-29.

55. Liang Y, Schott D, Zhang Y, Wang Z, Nasief H, Paulson E, Hall W, Knechtges P, Erickson B, Li XA. Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks. Radiother Oncol. 2020 Apr;145:193-200.

56. Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR. Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage Clinical Genitourinary Cancer. 2020.

57. W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore. Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) International Journal of Radiation Oncology, Biology, Physics. .

58. D. Schott W.A. Hall T. Gilat Schmidt E. Dalah K. Oshima E.S. Paulson P.M. Knechtges B.A. Erickson A. Li. Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer International Journal of Radiation Oncology, Biology, Physics. ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016.

59. W.A. Hall E.S. Paulson A. Vistocky S. Tsai E.J. Koay P.M. Knechtges D. Evans K. Christians P. Ritch B. George K. Oshima A. Li B.A. Erickson. Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate With Pathologic Molecular Markers: An Exploratory Analysis International Journal of Radiation Oncology, Biology, Physics. POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E178-E179, OCTOBER 01, 2016.

60. S. Moningi A. Amer L.E. Colbert Y. Lee W.A. Hall B.A. Erickson G.R. Varadhachary P. Das C.M. Taniguchi J.B. Fleming M. Katz C.H. Crane E.J. Koay. A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy International Journal of Radiation Oncology, Biology, Physics. POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016.

61. D. Watkins Bruner S.L. Pugh W.R. Lee J.J. Dignam D. Low G.P. Swanson A.B. Shah D.P. D'Souza J.M. Michalski I.S. Dayes S.A. Seaward P.L. Nguyen W.A. Hall T.M. Pisansky Y. Chen H.M. Sandler B. Movsas . NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results International Journal of Radiation Oncology, Biology, Physics. ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S2-S3, OCTOBER 01, 2016.

62. L.E. Colbert K.V. Dharmarajan J. Switchenko C.M. Taniguchi W.A. Hall T.W. Gillespie D.A. Kooby J. Lipscomb J.C. Landry. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) International Journal of Radiation Oncology, Biology, Physics. EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016.

63. D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall. Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC) International Journal of Radiation Oncology Biology Physics.

64. H. Nasief, E. Omari, Y. Zhang, X. Chen, A.K. Parchur, E.S. Paulson, W.A. Hall, B.A. Erickson, A. Li. Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy International Journal of Radiation Oncology Biology Physics.

65. A.M. Schottstaedt, E.S. Paulson, J. Rubenstein, X. Chen, E. Omari, A. Li, E.M. Gore, C.J. Schultz, W.A. Hall. Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac International Journal of Radiation Oncology Biology Physics. VOLUME 111, ISSUE 3, SUPPLEMENT , E75-E76, NOVEMBER 01, 2021

66. X. Chen, E.S. Paulson, M. Patel, W.A. Hall, A. Li. Exploring Correlation Between CT Number and ADC Value for Understanding Radiation Response International Journal of Radiation Oncology Biology Physics.

67. Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth J, Gross HM, Peterson RA, Faller B, Moxley K, Jacobs S, Stella P, Haddock MG, Hong TS, George TJ. Prospective Validation of the Magnetic Resonance Tumor Regression Grade (MR-TRG) and Correlation With Pathologic Endpoints Score in NRG Oncology GI002 International journal of radiation oncology, biology, physics. 1 November 2021;111(3):S37.

68. Amjad A, Xu J, Zhu X, Buchanan L, Kun T, O'Connell N, Thill D, Erickson BA, Hall WA, Li A. Deep Learning Auto-Segmentation on Multi-Sequence MRI for MR-Guided Adaptive Radiation Therapy International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e107.

69. Schottstaedt AM, Paulson ES, Rubenstein J, Chen X, Omari E, Li A, Gore EM, Schultz CJ, Hall WA. Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e75-e76.

70. Chen X, Paulson ES, Patel M, Hall WA, Li A. Exploring Correlation Between CT Number and ADC Value for Understanding Radiation Response International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e130.

71. Nguyen PL, Huang HC, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko J, Pollack A, Dicker AP, Roach M, Rosenthal SA, Morginstin M, Mendez L, Hartford AC, Hall WA, Desai AB, Rabinovitch R, Peters CA, Rodgers J, Feng FY. Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer International journal of radiation oncology, biology, physics. 1 November 2021;111(3):S50.

72. Zhang Y, Liang Y, Hall WA, Paulson ES, Chen X, Erickson BA, Li A. A Generalizable Guided Deep Learning Auto-Segmentation Method of Pancreatic GTV on Multi-Protocol Daily MRIs for MR-Guided Adaptive Radiotherapy International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e113.

73. Kerns SL, Morlang A, Lee SM, Hall WA, Peterson D, Marples B, Zhang H, Bylund KC, Rosenzweig D, de Ruyck K, Rosenstein BS, CaamaNo AG, Vega A, Parker C, West CML, Janelsins M, Chen Y, Messing E, Morrow G. Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e280-e281.

74. Daamen LA, de Mol van Otterloo SR, van Goor IWJM, Eijkelenkamp H, Erickson BA, Hall WA, Heerkens HD, Meijer GJ, Molenaar IQ, van Santvoort HC, Verkooijen HM, Intven MPW. Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac. Acta Oncol. 2022 Jan;61(1):111-115.

75. Cooper B, Bedi M, Bovi JA, Currey AD, Erickson BA, Gore EM, Hall WA, Lawton CAF, Schultz CJ, Siker ML, Saeed H. Enhancing Patient-Physician Experience in the Digital Era: A Review of Mobile Health Applications for Oncology Patients. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105-e106.

76. Wittman D, Paulson ES, Eastwood D, Banerjee A, Banla LI, Schultz CJ, Awan MJ, Chen X, Omari E, Straza MW Jr, Li A, Erickson BA, Hall WA. Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC). Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):S48-S49.

77. Feng J, Erickson BA, Currey AD, Shukla ME, Desai N, Bergom C, Hall WA. Attitudes and Beliefs Towards Medical Checklists in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):S112-S113.

78. Ortiz S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians K, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Erickson BA, Hall WA. Examination for the Presence of an Oligo-Metastatic State in Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e66-e67.

79. Conger R, Mora J, Straza MW Jr, Erickson BA, Lawton CAF, Schultz CJ, Currey AD, Bedi M, Saeed H, Tsai S, Siker ML, Hall WA. Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105.

80. Omari E, Nasief H, Zhang Y, Parchur AK, Paulson ES, Chen X, Ahunbay EE, Hall WA, Erickson BA, Li A. Should Daily Online Adaptive Replanning be Utilized for Every Treatment in MRI-Guided Radiotherapy for Pancreatic Cancer? Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e66.

81. Nasief H, Omari E, Zhang Y, Chen X, Parchur AK, Paulson ES, Hall WA, Erickson BA, Li A. Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy International journal of radiation oncology, biology, physics. 1 November 2021;111(3):S55.

82. Jassar H, Tai A, Chen X, Keiper T, Paulson ES, Lathuiliere F, Bériault S, Cooper D, Hebert F, Savard L, Cloake S, Hall WA, Lawton CAF, Li A. Real-Time Motion Tracking Based on Orthogonal Cine MRI During MR-Guided Radiation Therapy for Prostate Cancer International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e541.

83. Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS. Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy Advances in Radiation Oncology. 1 January 2023;8(1).

84. Noid G, Godfrey G, Hall W, Shah J, Paulson E, Knechtges P, Erickson B, Allen Li X. Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2023 Mar 01;115(3):803-808.

85. Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. Ann Surg Oncol. 2023 May;30(5):3013-3021.

86. Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN. Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy. Pract Radiat Oncol. 2023;13(3):e261-e269.

87. Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA. Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Advances in Radiation Oncology. 1 July 2023;8(4).

88. Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S. Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. J Surg Oncol. 2023 Jul;128(1):41-50.

89. Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S. ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer. Ann Surg Oncol. 2023 May;30(5):3022.

90. Kerns SL, Hall WA, Marples B, West CML. Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon Seminars in Radiation Oncology. 2023.

91. Erickson BA, Hall WA. Role of Radiation for Locally Advanced Pancreatic Cancer Management of Localized Pancreatic Cancer: Current Treatment and Challenges. 1 January 2019:113-132.

92. Kerns SL, Hall WA, Marples B, West CML. Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon. Semin Radiat Oncol. 2023 Jul;33(3):307-316.

93. Lo Russo M, Nachbar M, Barry A, Bhide S, Chang A, Hall W, Intven M, Marijnen C, Peters F, Minsky B, Romesser PB, Sarkar R, Tan A, Boeke S, Wegener D, Butzer S, Boldt J, Gatidis S, Nikolaou K, Thorwarth D, Zips D, Gani C. Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation Clinical and Translational Radiation Oncology. January 2023;38:1-5.

94. Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB . The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer. . 2013 Sep 15;119(18):3272-9.

95. Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer.. 2014 Feb 15;120(4):499-506 PMID: 24390739.

96. Hall WA, Hardy CW, Colbert LE, Landry JC, Fisher SB, Sarka B, Petrova AV, Pantazides BG, Maithel SK, Kowalski J, Gandhi K, Kooby D, El-Rayes BF, Staley CA, Adsay V, Yu DS.. Chromodomain Helicase Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival In Patients Undergoing Adjuvant Therapy For Resected Pancreatic Adenocarcinoma. Oncogene.. ePub Nov 25, 2013. PMID: 24276239..

97. Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. Pract Radiat Oncol. 2017;7(2):126-136.

98. Hall WA, Erickson B. Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. J Oncol Pract. 2017 Mar;13(3):171-172.

99. Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA. Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. PLoS One. 2017;12(6):e0178961. PMCID: PMC5456365

100. Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? Pract Radiat Oncol. 2017;7(6):e449-e455.

101. Barnes CA, Tsai S, Hall WA, Erickson BA, Evans DB. Neoadjuvant chemoradiation for operable pancreatic cancer: The importance of local disease control Pancreatic Cancer. 11 April 2018:1219-1237.

102. Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 Sep 01;124(17):3510-3519. PMCID: PMC10450543

103. ShreeMahadevan L, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, Triest B, Krishnan S, Hall W. Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]. Crit Rev Oncol Hematol. 2019 Feb;134:71.

104. Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline Practical Radiation Oncology. September - October 2019;9(5):322-332.

105. Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B, Li XA. Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. Front Oncol. 2019;9:1464. PMCID: PMC6960122

106. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. HPB (Oxford). 2020 Dec;22(12):1745-1752.

107. Amjad A, Xu J, Thill D, Zhang Y, Ding J, Paulson E, Hall W, Erickson BA, Li XA. Deep learning auto-segmentation on multi-sequence magnetic resonance images for upper abdominal organs. Front Oncol. 2023;13:1209558. PMCID: PMC10358771

108. Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA. Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator Physics and Imaging in Radiation Oncology. October 2023;28.

109. Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, Christodouleas JP, Hall WA, Verkooijen H, Intven MPW. Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e291.

110. Westley R, Peltenburg J, Aitken KL, Awan MJ, Braam PM, Daamen LA, Hosni A, Intven MPW, Janssen T, Schytte T, Sonke JJ, Straza MW Jr, Paulson ES, Hall WA, Nowee ME. Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e156.

111. Ponce SEB, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, de Choudens SO, Erickson BA, Hall WA. Patterns of Locoregional Pancreatic Cancer Recurrence after Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e284-e285.

112. Peltenburg J, Hosni A, Bahij R, Böke S, Braam PM, Hall WA, Intven MPW, Nicosia LD, Sonke JJ, Nowee ME, Janssen T. Interobserver Variation in Tumor Delineation of Liver Metastases using Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e145.

113. Daamen LA, Westerhoff JM, Christodouleas JP, Orrling K, Eggert D, Choudhury A, Fuller CD, van der Heide U, Sahgal A, Schultz CJ, Schytte T, Tersteeg R, Tree A, Hall WA, Verkooijen H. Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e576-e577.

114. Phillips R, Proudfoot J, Davicioni E, Spratt DE, Feng FY, Simko J, Den RB, Pollack A, Rosenthal SA, Sartor O, Sweeney C, Attard G, Patel SI, Hall WA, Efstathiou JA, Shah AB, Hoffman KE, Pugh S, Sandler HM, Tran PT. Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S34-S35.

115. Amjad A, Chen X, Hall WA, Lawton CAF, Li A, Paulson ES. Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e638-e639.

116. Lee WR, Dignam JJ, Amin M, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes I, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Rodgers J, Sandler HM. Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S3-S4.

117. Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA. Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S114-S115.

118. Zhang Y, Amjad A, Ding J, Sarosiek C, Zarenia M, Conlin R, Dang NP, Hall WA, Erickson BA, Paulson ES, Li A. Clinical Usability-Oriented Automatic Contour Quality Evaluation for Deep Learning Auto-Segmentation. Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S144-S145.

119. Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW. Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study Clinical and Translational Radiation Oncology. March 2024;45.

120. Sritharan K, Daamen L, Pathmanathan A, Schytte T, Pos F, Choudhury A, van der Voort van Zyp JRN, Kerkmeijer LGW, Hall W, Hall E, Verkooijen HM, Herbert T, Hafeez S, Mitchell A, Tree AC. MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study Clinical and Translational Radiation Oncology. May 2024;46.

121. Kong M, DeSilvio T, Bao L, Flannery B, Parker BN, Tang S, Labbad M, O’Connor G, Gupta A, Steinhagen E, Purysko AS, Hall W, Liska D, Marderstein EL, Carroll A, Crittenden M, Gough M, Young K, Viswanath SE. Human-in-the-Loop Informed Deep Learning Rectal Tumor Segmentation on Pre-Treatment MRI Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2024;12927.

1. Hall WA, Erickson BA. Neoadjuvant Chemoradiation for Localized Pancreatic Cancer Management of Localized Pancreatic Cancer: Current Treatment and Challenges. 1 January 2019:85-96.

1. 63/483,252 MCW Owned Patient Title: Monitoring Organ Morphology for Radiation Treatment Delivery Using Ultrasound